Pulmonary Non-tuberculous Mycobacterial Infections in Category II Failures from National Tuberculosis Programme
Y. N. Dholakia, D. P. Shah
Keywords :
Pulmonary NTM infection, Treatment
Citation Information :
Dholakia YN, Shah DP. Pulmonary Non-tuberculous Mycobacterial Infections in Category II Failures from National Tuberculosis Programme. Indian J Chest Dis Allied Sci 2015; 57 (1):27-30.
Pulmonary infections due to non-tuberculous mycobacteria (NTM) are increasingly being reported. These can mimic drugresitant tubercuolosis. A diagnosis of NTM infections needs a high degree of clinical suspicion and repeated isolation of the organism on culture. NTM infections occur commonly in immunocompromised individuals and in people with lung abnormalities. Currently there are no guidelines on drug combinations and the duration of treatment is not adequately defined.
Two cases of pulmonary infection with NTM in immune-competent individuals are described in the present report. Although the bacteriological, radiological and clinical response to treatment was good; early discontinuation of treatment resulted in recurrence and change in drug susceptibility pattern, suggesting the need for prolonged treatment for achieving cure.
Saleeb P, Olivier KN. Pulmonary nontuberculous mycobacterial disease: new insights into risk factors for susceptibility, epidemiology, and approaches to management in immunocompetent and immunocompromised patients. Curr Infect Dis Rep 2010;12:198-203.
Katoch VM. Infections due to non-tuberculous mycobacteria (NTM). Indian J Med Res 2004;120:290-304.
Dholakia Y, Shah D. Clinical profile and treatment outcomes of drug-resistant tuberculosis before directly observed treatment strategy plus: lessons for the program. Lung India 2013;30:316-20.
Jun HJ, Jeon K, Um SW, Kwon OJ, Lee NY, Koh WJ. Nontuberculous mycobacteria isolated during the treatment of pulmonary tuberculosis. Respir Med 2009;103:1936-40.
Marras TK, Daley CL. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med 2002;23:553-67.
Prevots DR, Shaw PA, Strickland D, Jackson LA, Raebel MA. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med 2010;182:970-6.
Mistry NF, Dholakia Y, D'Souza DTB, Taylor M, Hoffner S, Birdi TJ. Rhodococcus and Mycobacterium tuberculosis: masquerade or mixed infection. Int J Tuberc Lung Dis 2006;10:351-3.
Piersimoni C, Scarparo C. Pulmonary infections associated with non tuberculous mycobacteria in immunocompetentpatients. Lancet Infect Dis 2008;8:323-34.
Bicmen C, Coskun M, Gunduz AT, Senol G, Cirak AK, Tibet G. Nontuberculous mycobacteria isolated from pulmonary specimens between 2004 and 2009: causative agent or not. New Microbiologica 2010;33:399-403.
Sarin R, Singla R, Visalakshi P, Jaiswal A, Puri MM, Khalid UK, et al. Smear microscopy as surrogate for culture during follow up of pulmonary MDR TB patients on DOTS plus treatment. Indian J Tuberc 2010;57:134-40.
Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society. Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999. Thorax 2000;55:210-18.
Jiang SH, Roberts DM, Dawson AH, Jardine M. Mycobacterium fortuitum as a cause of peritoneal dialysisassociated peritonitis: case report and review of the literature. BMC Nephrol 2012;13:35.
